Hapvida (B3: HAPV3) revenue
Hapvida reported revenue of BRL 31,577m for fiscal 2025, 9.2% more than in fiscal 2024 (BRL 28,915m). Since fiscal 2017 its revenue has grown by 720.6%, an average growth of 30.1% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | BRL 31,577m | +9.2% | BRL 1,457m | 4.6% |
| 2024 | BRL 28,915m | +4.1% | BRL 741.0m | 2.6% |
| 2023 | BRL 27,770m | +16.9% | BRL 1,172m | 4.2% |
| 2022 | BRL 23,749m | +140.3% | −BRL 155.9m | −0.7% |
| 2021 | BRL 9,883m | +15.5% | BRL 543.3m | 5.5% |
| 2020 | BRL 8,555m | +51.8% | BRL 1,267m | 14.8% |
| 2019 | BRL 5,634m | +23.1% | BRL 1,033m | 18.3% |
| 2018 | BRL 4,576m | +18.9% | BRL 870.5m | 19.0% |
| 2017 | BRL 3,848m | — | BRL 783.5m | 20.4% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of Brazilian reais, except per-share amounts.
Questions about the revenue of Hapvida
- How much revenue did Hapvida make in fiscal 2025?
- Hapvida reported revenue of BRL 31,577m for fiscal 2025, compared with BRL 28,915m in fiscal 2024.
- How much has the revenue of Hapvida grown?
- Between fiscal 2017 and fiscal 2025 it went from BRL 3,848m to BRL 31,577m: 720.6% more, an average growth of 30.1% a year.
- What was the best year for revenue at Hapvida?
- Of its last 9 fiscal years, fiscal 2025, with BRL 31,577m.
- Where do the figures for Hapvida come from?
- From the annual financial statements (DFP) that Hapvida files with the CVM, the Brazilian securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual financial statements (DFP) that Hapvida files with the CVM, the Brazilian securities regulator. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Hapvida: the Hapvida page · annual accounts · net income.
More companies from Brazil and the rest of the region: Latin American stocks.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.